 | • レポートコード：QYR2104Z5418 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、扁平上皮非小細胞肺がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BMS-906024、塩酸ブパリシブ、FP-1039、イピリムマブ、JNJ-42756493、レンバチニブ、その他）、用途別市場規模（研究センター、病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・扁平上皮非小細胞肺がん治療薬の市場動向 ・企業の競争状況、市場シェア ・扁平上皮非小細胞肺がん治療薬の種類別市場規模（BMS-906024、塩酸ブパリシブ、FP-1039、イピリムマブ、JNJ-42756493、レンバチニブ、その他） ・扁平上皮非小細胞肺がん治療薬の用途別市場規模（研究センター、病院、クリニック） ・扁平上皮非小細胞肺がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・扁平上皮非小細胞肺がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・扁平上皮非小細胞肺がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・扁平上皮非小細胞肺がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・扁平上皮非小細胞肺がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ascenta Therapeutics, Inc.、AstraZeneca Plc、AVEO Pharmaceuticals, Inc.、Bayer AG、BIND Therapeutics, Inc.、Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、Five Prime Therapeutics, Inc.、Genentech, Inc.、Incyte Corporation、Johnson & Johnson、MacroGenics, Inc.、Novartis AG、Oncogenex Pharmaceuticals, Inc.、PsiOxus Therapeutics Limited） ・結論 |
Market Analysis and Insights: Global Squamous Non-Small Cell Lung Cancer Therapeutics Market
The global Squamous Non-Small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Squamous Non-Small Cell Lung Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Squamous Non-Small Cell Lung Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Squamous Non-Small Cell Lung Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Squamous Non-Small Cell Lung Cancer Therapeutics market.
Global Squamous Non-Small Cell Lung Cancer Therapeutics Scope and Market Size
Squamous Non-Small Cell Lung Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Squamous Non-Small Cell Lung Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
BMS-906024
Buparlisib Hydrochloride
FP-1039
Ipilimumab
JNJ-42756493
Lenvatinib
Others
Segment by Application
Research Center
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Ascenta Therapeutics, Inc.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Bayer AG
BIND Therapeutics, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Bayer AG
BIND Therapeutics, Inc.
Incyte Corporation
Johnson & Johnson
MacroGenics, Inc.
Novartis AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 BMS-906024
1.2.3 Buparlisib Hydrochloride
1.2.4 FP-1039
1.2.5 Ipilimumab
1.2.6 JNJ-42756493
1.2.7 Lenvatinib
1.2.8 Others
1.3 Market by Application
1.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Perspective (2016-2027)
2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Dynamic
2.3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends
2.3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers
2.3.3 Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges
2.3.4 Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue
3.1.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue
3.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2020
3.5 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
6.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
6.2.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
6.3.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
6.4.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
7.2.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
7.3.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
7.4.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
9.2.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
9.3.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
9.4.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ascenta Therapeutics, Inc.
11.1.1 Ascenta Therapeutics, Inc. Company Details
11.1.2 Ascenta Therapeutics, Inc. Business Overview
11.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.1.4 Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.1.5 Ascenta Therapeutics, Inc. Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.2.4 AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 AVEO Pharmaceuticals, Inc.
11.3.1 AVEO Pharmaceuticals, Inc. Company Details
11.3.2 AVEO Pharmaceuticals, Inc. Business Overview
11.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.3.4 AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.3.5 AVEO Pharmaceuticals, Inc. Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.4.4 Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.4.5 Bayer AG Recent Development
11.5 BIND Therapeutics, Inc.
11.5.1 BIND Therapeutics, Inc. Company Details
11.5.2 BIND Therapeutics, Inc. Business Overview
11.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.5.4 BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.5.5 BIND Therapeutics, Inc. Recent Development
11.6 Boehringer Ingelheim GmbH
11.6.1 Boehringer Ingelheim GmbH Company Details
11.6.2 Boehringer Ingelheim GmbH Business Overview
11.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.6.4 Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.6.5 Boehringer Ingelheim GmbH Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.8.4 Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Company Details
11.9.2 F. Hoffmann-La Roche Ltd. Business Overview
11.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.9.4 F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.9.5 F. Hoffmann-La Roche Ltd. Recent Development
11.10 Five Prime Therapeutics, Inc.
11.10.1 Five Prime Therapeutics, Inc. Company Details
11.10.2 Five Prime Therapeutics, Inc. Business Overview
11.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.10.4 Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.10.5 Five Prime Therapeutics, Inc. Recent Development
11.11 Genentech, Inc.
11.11.1 Genentech, Inc. Company Details
11.11.2 Genentech, Inc. Business Overview
11.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.11.4 Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.11.5 Genentech, Inc. Recent Development
11.12 Incyte Corporation
11.12.1 Incyte Corporation Company Details
11.12.2 Incyte Corporation Business Overview
11.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.12.4 Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.12.5 Incyte Corporation Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.13.4 Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.13.5 Johnson & Johnson Recent Development
11.14 MacroGenics, Inc.
11.14.1 MacroGenics, Inc. Company Details
11.14.2 MacroGenics, Inc. Business Overview
11.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.14.4 MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.14.5 MacroGenics, Inc. Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.15.4 Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.15.5 Novartis AG Recent Development
11.16 Oncogenex Pharmaceuticals, Inc.
11.16.1 Oncogenex Pharmaceuticals, Inc. Company Details
11.16.2 Oncogenex Pharmaceuticals, Inc. Business Overview
11.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.16.4 Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.16.5 Oncogenex Pharmaceuticals, Inc. Recent Development
11.17 PsiOxus Therapeutics Limited
11.17.1 PsiOxus Therapeutics Limited Company Details
11.17.2 PsiOxus Therapeutics Limited Business Overview
11.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Introduction
11.17.4 PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
11.17.5 PsiOxus Therapeutics Limited Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of BMS-906024
Table 3. Key Players of Buparlisib Hydrochloride
Table 4. Key Players of FP-1039
Table 5. Key Players of Ipilimumab
Table 6. Key Players of JNJ-42756493
Table 7. Key Players of Lenvatinib
Table 8. Key Players of Others
Table 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Table 15. Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends
Table 16. Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers
Table 17. Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges
Table 18. Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints
Table 19. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2020)
Table 22. Ranking of Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service
Table 26. Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Ascenta Therapeutics, Inc. Company Details
Table 67. Ascenta Therapeutics, Inc. Business Overview
Table 68. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 69. Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Ascenta Therapeutics, Inc. Recent Development
Table 71. AstraZeneca Plc Company Details
Table 72. AstraZeneca Plc Business Overview
Table 73. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 74. AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca Plc Recent Development
Table 76. AVEO Pharmaceuticals, Inc. Company Details
Table 77. AVEO Pharmaceuticals, Inc. Business Overview
Table 78. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 79. AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 80. AVEO Pharmaceuticals, Inc. Recent Development
Table 81. Bayer AG Company Details
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 84. Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Bayer AG Recent Development
Table 86. BIND Therapeutics, Inc. Company Details
Table 87. BIND Therapeutics, Inc. Business Overview
Table 88. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 89. BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 90. BIND Therapeutics, Inc. Recent Development
Table 91. Boehringer Ingelheim GmbH Company Details
Table 92. Boehringer Ingelheim GmbH Business Overview
Table 93. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 94. Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Boehringer Ingelheim GmbH Recent Development
Table 96. Bristol-Myers Squibb Company Company Details
Table 97. Bristol-Myers Squibb Company Business Overview
Table 98. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 99. Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Bristol-Myers Squibb Company Recent Development
Table 101. Eli Lilly and Company Company Details
Table 102. Eli Lilly and Company Business Overview
Table 103. Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Eli Lilly and Company Recent Development
Table 105. F. Hoffmann-La Roche Ltd. Company Details
Table 106. F. Hoffmann-La Roche Ltd. Business Overview
Table 107. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 108. F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 109. F. Hoffmann-La Roche Ltd. Recent Development
Table 110. Five Prime Therapeutics, Inc. Company Details
Table 111. Five Prime Therapeutics, Inc. Business Overview
Table 112. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 113. Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Five Prime Therapeutics, Inc. Recent Development
Table 115. Genentech, Inc. Company Details
Table 116. Genentech, Inc. Business Overview
Table 117. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 118. Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Genentech, Inc. Recent Development
Table 120. Incyte Corporation Company Details
Table 121. Incyte Corporation Business Overview
Table 122. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 123. Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Incyte Corporation Recent Development
Table 125. Johnson & Johnson Company Details
Table 126. Johnson & Johnson Business Overview
Table 127. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 128. Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Johnson & Johnson Recent Development
Table 130. MacroGenics, Inc. Company Details
Table 131. MacroGenics, Inc. Business Overview
Table 132. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 133. MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 134. MacroGenics, Inc. Recent Development
Table 135. Novartis AG Company Details
Table 136. Novartis AG Business Overview
Table 137. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 138. Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Novartis AG Recent Development
Table 140. Oncogenex Pharmaceuticals, Inc. Company Details
Table 141. Oncogenex Pharmaceuticals, Inc. Business Overview
Table 142. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 143. Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 144. Oncogenex Pharmaceuticals, Inc. Recent Development
Table 145. PsiOxus Therapeutics Limited Company Details
Table 146. PsiOxus Therapeutics Limited Business Overview
Table 147. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 148. PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 149. PsiOxus Therapeutics Limited Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. BMS-906024 Features
Figure 3. Buparlisib Hydrochloride Features
Figure 4. FP-1039 Features
Figure 5. Ipilimumab Features
Figure 6. JNJ-42756493 Features
Figure 7. Lenvatinib Features
Figure 8. Others Features
Figure 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Research Center Case Studies
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Squamous Non-Small Cell Lung Cancer Therapeutics Report Years Considered
Figure 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Players in 2020
Figure 19. Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2020
Figure 21. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Region (2016-2027)
Figure 43. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Ascenta Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 63. AstraZeneca Plc Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 64. AVEO Pharmaceuticals, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 65. Bayer AG Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 66. BIND Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 67. Boehringer Ingelheim GmbH Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 68. Bristol-Myers Squibb Company Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 69. Eli Lilly and Company Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 70. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 71. Five Prime Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 72. Genentech, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 73. Incyte Corporation Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 74. Johnson & Johnson Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 75. MacroGenics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 76. Novartis AG Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 77. Oncogenex Pharmaceuticals, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 78. PsiOxus Therapeutics Limited Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…